Melatonin is a potential drug for the prevention of bone loss during space flight.
Ontology highlight
ABSTRACT: Astronauts experience osteoporosis-like loss of bone mass because of microgravity conditions during space flight. To prevent bone loss, they need a riskless and antiresorptive drug. Melatonin is reported to suppress osteoclast function. However, no studies have examined the effects of melatonin on bone metabolism under microgravity conditions. We used goldfish scales as a bone model of coexisting osteoclasts and osteoblasts and demonstrated that mRNA expression level of acetylserotonin O-methyltransferase, an enzyme essential for melatonin synthesis, decreased significantly under microgravity. During space flight, microgravity stimulated osteoclastic activity and significantly increased gene expression for osteoclast differentiation and activation. Melatonin treatment significantly stimula
SUBMITTER: Ikegame M
PROVIDER: S-EPMC6771646 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA